Oracle 的合同研究组织 (CRO) 增长计划可助您加速业务发展
借助 Oracle CRO Growth Initiative，建立差异化优势，赢得更多申办方客户，并提高临床试验的效率和效益。
加速业务发展
在临床研究领域，如何在保证质量和安全的前提下加快研究速度至关重要。我们认识到 CRO 正在竞相吸引和赢得更多申办方的业务，因此我们设计了 CRO Growth Initiative，其中包括加速器。此计划为您提供了独特的进入市场优势、技术支持和激励措施，帮助您在使用先进的临床技术平台 Oracle Life Sciences Clinical One 提供专业服务时，能够更好地规划、执行、评估并奖励您的成就。
有哪些优势？
伙伴关系管理
根据双方达成的业务策略，提供 CRO 的专用资源，帮助您加快服务增长并取得成功。
免费培训和支持
Clinical One 认证和灵活而强大的培训计划可帮助建立销售和服务专业知识，赢得新业务。
业务发展支持
进入市场策略可帮助提升您的品牌，并为联合销售和竞标提供 RFx 支持。
增长激励措施
提供 Clinical One 单次试用服务储值和为期 12 个月的免费非生产性 Clinical One 云技术环境。
Why Oracle?
Oracle is committed to providing innovative, future-proof clinical and safety solutions that support crucial services that you provide throughout the clinical development lifecycle—from study design and startup to conduct, closeout, and post-marketing. Gain a competitive edge to win more business using proven and trusted clinical systems that can support any trial size and therapeutic area to meet the needs of your customers and patients.
About 10M
adverse events processed last year
406
unique health authorities were data beneficiaries
91%
of all vaccine adverse events reported to the FDA1
More than 3M
safety cases supported last year from a single client2
More than 250K
total clinical studies managed
28 of 30
top pharmaceutical companies worldwide use Oracle clinical systems
1 Vaccine Adverse Event Reporting System (VAERS) publicly available datasets, 2017 to 2022 week 19.
2 Data from single customer.
Why are CROs collaborating with Oracle to grow their business?
“The free enablement and non-production environment for Clinical One has empowered our study build team and data managers to become SMEs in a very short timeframe which allows Accelsiors to deliver successful studies to their sponsors.”
“Oracle's CRO Growth Initiative has elevated Oracle's commitment to CROs in reducing the barriers to adopting new technology to meet the needs of our customers, all at no risk to us.”
“We're excited to join the CRO Growth Initiative. With no risk, trials credits, and additional support, it just made good business sense.”
“FHI Clinical chose Oracle's Clinical One platform as our default clinical system because it is built the way we would have built for ourselves - single data source, united platform, intuitive, and cost efficient.”
“As a growing CRO, we are excited that Oracle, Oracle's CRO Growth Initiative and Clinical One are supporting our business goals to grow and address new markets.”
赶快行动
联系我们
请联系我们，咨询有关参与 CRO Growth Initiative 的事宜。
注：为免疑义，本网页所用以下术语专指以下含义：
- 除Oracle隐私政策外，本网站中提及的“Oracle”专指Oracle境外公司而非甲骨文中国。
- 相关Cloud或云术语均指代Oracle境外公司提供的云技术或其解决方案。